CRISPR Therapeutics Newsroom

CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)

Earnings Call Transcripts11:37 ET

Trending Industry Today: Beam Therapeutics Leads Losses In Gene Editing Stocks

Moomoo NewsNov 15 10:30 ET

Cathie Wood's ARK Investment Bought 178.1K Shares of Crispr Therapeutics Today

TipRanksNov 14 20:05 ET

Gilead, Vertex Initiated as New Big Biotech Buys at Citi

Seeking AlphaNov 14 14:26 ET

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

GlobeNewswireNov 14 08:30 ET

ARKK's Holdings Ranked by SA Quant Grades

Seeking AlphaNov 12 14:21 ET

Form 144 | CRISPR Therapeutics(CRSP.US) Officer Proposes to Sell 4.11 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Nov 12, $CRISPR Therapeutics(CRSP.US)$ Officer Dr. Samarth Kulkarni intends to sell 75,000 shares of its common stock on Nov 11, with a total market value of approximately $4.1

Moomoo NewsNov 12 13:13 ET

Cathie Wood's ARK Innovation ETF Is a Trump Trade Winner as Tesla Soars. But It Still Lags the Market.

BarronsNov 12 11:38 ET

Capsida Biotherapeutics to Present New Preclinical Data for Potential Best-in-Class Friedreich's Ataxia Next-Generation Gene Therapy

PR NewswireNov 12 07:45 ET

Mizuho Securities Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating

Moomoo NewsNov 12 03:33 ET · Ratings

Positive Outlook on Crispr Therapeutics AG Driven by Strong Pricing and Strategic Partnerships

TipRanksNov 12 02:47 ET

CRISPR, Beam, Other Gene Editing Names up Significantly

Seeking AlphaNov 11 13:15 ET

Morgan Stanley Maintains CRISPR Therapeutics(CRSP.US) With Sell Rating, Maintains Target Price $45

Moomoo NewsNov 8 09:38 ET · Ratings

A Quick Look at Today's Ratings for CRISPR Therapeutics(CRSP.US), With a Forecast Between $30 to $95

Moomoo NewsNov 7 08:00 ET · Ratings

CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference

GlobeNewswireNov 7 08:00 ET

CRISPR Therapeutics AG (NASDAQ:CRSP) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Yahoo FinanceNov 7 07:42 ET

Cathie Wood's ARK Investment Bought 409.5K Shares of Crispr Therapeutics Today

TipRanksNov 6 20:11 ET

Trending Industry Today: Coinbase Leads Gains In ARK Portfolio Stocks

Moomoo NewsNov 6 14:30 ET

CRISPR Technology Market Report 2024, With Profiles of Major Players Agilent Technologies, Beam Therapeutics, Caribou Biosciences, Crispr Therapeutics, Danaher, Genscript, Lonza and More - ResearchAndMarkets.com

BusinesswireNov 6 12:21 ET

Express News | RBC Capital Reiterates Sector Perform on CRISPR Therapeutics, Maintains $53 Price Target

BenzingaNov 6 11:18 ET